ArticleCommunications biology2024

Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK.

Chang-Yu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.